BMY vs ECVT · P/E 17, rev $24.46B vs rev $464.9M
Bristol-Myers Squibb Company (BMY) versus Ecovyst Inc (ECVT) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Ecovyst Inc (ECVT) is a specialty chemicals company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ECVT revenue for 2026-06-30 was $464.9M. Net income was $12.2M. ECVT currently screens at market cap $892.2M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ECVT currently screens at market cap $892.2M.
Not investment advice. Open the BMY and ECVT stock pages for the full models.
Not investment advice.